are employees of MRC Holland (Amsterdam, the Netherlands), developer and manufacturer of multiplex ligation-dependent probe amplification reagents and probemixes. M.F.K. has provided consultancy for Abbvie, Janssen, BMS/Celgene, Karyopharm, GSK, Amgen, and Takeda; and received research funding to institution by Janssen and Celgene.